BPC-157 (Capsule)

BPC-157 Oral Capsule

Oral BPC-157 for gastrointestinal healing, gut permeability, and systemic anti-inflammatory effects.

100% 50% · t½ Time → Serum level
Molecular Weight
—
Half-Life
Varies
Typical Dose
One capsule (per prescriber guidance)
Cycle Length
4–12 weeks

Description

Oral BPC-157 capsules deliver the gastric pentadecapeptide directly to the gastrointestinal tract, where it exerts potent local healing effects on the mucosal lining. BPC-157 was originally isolated from human gastric juice and has demonstrated remarkable cytoprotective properties across hundreds of preclinical studies. While injectable BPC-157 is preferred for musculoskeletal injuries due to higher systemic bioavailability, oral administration is particularly effective for GI conditions including leaky gut syndrome, inflammatory bowel disease, GERD, and gut dysbiosis. Research has shown that oral BPC-157 can accelerate healing of intestinal anastomoses, protect against NSAID-induced GI damage, and normalize gut motility disrupted by various insults. The oral route also allows for convenient once or twice daily dosing without the need for reconstitution or injection.

Key Characteristics

Half-LifeVaries
Administration RoutesOral capsule
Typical DoseOne capsule (per prescriber guidance)
FrequencyOnce or twice daily

Investigated Benefits

  • GI tract healing
  • Leaky gut repair
  • Reduced gut inflammation
  • GERD improvement
  • Systemic anti-inflammatory effects

* Benefits based on preclinical/animal research unless otherwise noted.